Form 4: Upstream Bio CEO Sells Shares for Tax Withholding

Everett Rand, CEO of Upstream Bio, Inc., reported the sale of 2,095 shares of common stock on June 16, 2026, to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Everett Rand, Chief Executive Officer and Director of Upstream Bio, Inc., reported a transaction on June 16, 2026.
• The transaction involved the sale of 2,095 shares of common stock.
• These shares were sold at a price of $6.10 per share.
• The sale was conducted under the company's 'sell-to-cover' policy to satisfy tax withholding obligations associated with the vesting of restricted stock units.
• The sales were automatic and not at the discretion of Mr. Rand.
• Following this transaction, Mr. Rand beneficially owns 70,812 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine administrative transaction for tax compliance rather than a strategic business development or financial performance indicator.

Positives

• The sale was executed automatically under a pre-defined company policy ('sell-to-cover') to manage tax obligations, indicating a structured approach to executive compensation and tax compliance.
• The transaction ensures that tax liabilities are met without requiring the executive to personally fund them, preserving liquidity.

Negatives

• A portion of the executive's equity holdings was sold, which could be perceived negatively by some investors if not for the clear explanation of tax withholding.

Risks

• The primary risk is the potential for misinterpretation of the share sale by the market, leading to unwarranted negative sentiment if the 'sell-to-cover' nature is not understood.

Future Outlook

This filing does not contain forward-looking statements or guidance. It solely reports a past transaction.

Management Comments

• The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
• Such sales were automatic and not at the discretion of the Reporting Person.

Industry Context

StockSavvy.ai notes that 'sell-to-cover' transactions are a common and accepted method for executives to manage tax liabilities arising from equity compensation, particularly with the increasing prevalence of restricted stock units and performance shares.

Stakeholder Impact

• Shareholders: The transaction is a routine tax-related sale and is unlikely to have a significant direct impact on the share price or company fundamentals, provided the 'sell-to-cover' nature is understood.
• Employees: The transaction relates to executive compensation and tax management, with no direct impact on general employee compensation or benefits.
• Management: Ensures the CEO can meet tax obligations related to equity compensation, maintaining compliance and personal financial management.

Next Steps

• No specific next steps are outlined in this filing beyond the completion of the reported transaction.

Key Dates

Keywords

Form 4, SEC Filing, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Executive Compensation, Upstream Bio, Inc., Everett Rand, Sell-to-cover